starburst icon
The t:slim, t:slim G4, and t:flex insulin pumps are no longer in production. Ordering of supplies, including t:flex cartridges, through Tandem Diabetes Care will no longer be available and Customer Technical Support will no longer provide immediate, live support after July 1, 2023.

Technical Support

Access and browse an extensive library of educational and self-help materials, including user guides and helpful videos, to help you get the most out of your insulin pump.

Request Support Online

Please fill out the following form to request support for your t:slim, t:slim G4, or t:flex insulin pump. A customer service specialist will contact you within (or up to) 24 hours.

t:slim X2 Insulin Pump

Note: Please provide the serial number for your insulin pump in the form field below. If the pump in your possession is currently turned off, the serial number can be found on the back of the pump, where the cartridge slides on, and below the barcode. If your pump is powered on, tap Options, My Pump, and then Pump Info to find the number.

Pump Renewal

If you haven’t already, you can upgrade to a t:slim X2 insulin pump with Control-IQ+ technology.

Important Safety Information

RX ONLY. The t:slim X2 pump with interoperable technology (the pump) and Control-IQ+ technology (Control-IQ+) are intended for single patient use. The pump and Control-IQ+ are indicated for use with NovoLog, Humalog, or Lyumjev U-100 insulin.

t:slim X2 insulin pump: The pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.

Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.

Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.

Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.